-
Shanton has screened the first subjects in the Phase II.b study of SAP-001 refractory/tophi gout
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];Shanton Pharma, a clinical-stage biotechnology company that has developed a breakthrough treatment for patients with refractory/tophi gout, announced the launch of the RID GOUT study, a Phase IIb study of Shanton's investigational drug, SAP-001, on January 9.
-
Fluorinated compounds and a high-carb diet
Time of Update: 2022-11-15
In addition, in order to make recommendations, the ADA committee must change its position on several key points:Safety of topical application of fluorideBone health nutrient deficiencies are the cause of tooth decay, from an "established fact" to an unequivocal denialThere is a need to teach dental patients that "reducing carbohydrate intake is necessary" and instead recommend a "balanced" diet, which is increasingly relevant to nutritional guidelines for high carbohydratesDr. Hujoel's research also explores the private interests involved in the U.
-
Xuyang Group's annual output of 300,000 tons of caprolactam expansion project is in full swing
Time of Update: 2022-10-14
At 11:38 on September 25, the second phase of the Cangzhou Park of Xuyang Group with an annual output of 300,000 tons of caprolactam expansion project successfully produced caprolactam excellent prod
-
Is Rheumatoid Arthritis an "Undead Cancer
Time of Update: 2022-10-11
With the joint efforts and communication of doctors and patients, choosing appropriate drug treatment, insisting on long-term medication and follow-up, and achieving and maintaining the treatment goals can control the development of the disease and reduce the pain and morning stiffness caused by rheumatoid arthritis.
-
Antisedatives can alleviate the side effects of cancer treatment
Time of Update: 2022-10-02
The researchers found that inhibiting GABA a receptor protected mice from the toxic side effects of chemotherapy or radiotherapy, reducing the amount of DNA damage and increasing the survival rate of intestinal stem cells.
-
Professor Xia Ningshao's team found that the pORF2 protein in urine is an excellent target for the diagnosis of hepatitis E virus
Time of Update: 2022-10-02
Hepatitis E Virus (HEV) is one of the leading pathogens of viral hepatitis worldwide. Patients with chronic liver disease, pregnant women, and the elderly are at high risk of HEV infection. After over
-
German chemical giant LANXESS acquires U.S. Emerald Kalama Chemical
Time of Update: 2022-08-27
4 billion) in funding to pursue deals, and Emerald Kalama would In line with its interest in higher-margin specialty chemical assets In fact, back in November 2020, Lanxess CEO Matthias Zachert said on an earnings call in November that the company had as much as 2 billion euros ($2.
-
Overcoming Barriers: How Rabbit Myxoma Virus Leaps into New Species
Time of Update: 2022-05-13
In a new study published in the journal mBio, Masmudur Rahman and his Arizona State University colleagues joined an international team of researchers to investigate one such spillover event, myxoma virus (MYXV) from Europe Rabbit crosses to the species of the Iberian hare .
-
"Building" a salt bridge to break the curse of "uncurable", the key target of the king of cancer
Time of Update: 2022-05-02
KRAS gene often 'untargetable'Zhang Yonghui, the corresponding author of the paper, said: "When we develop drugs, we will carefully observe the structure of the target protein and look for compounds that can bind to two key sites .
-
The Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance will open bids on February 25
Time of Update: 2022-05-02
On February 23, 2022, the Shanghai Pharmaceutical Centralized Bidding and Purchasing Administration issued the precautions for submitting application materials for centralized drug procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance .
-
Real-time monitoring of drug pharmacokinetics in living tumor tissue
Time of Update: 2022-01-25
We performed continuous in vivo monitoring of the concentration of the chemotherapeutic drug doxorubicin at multiple tumor sites in rodent models and demonstrated clear differences in circulation-related pharmacokinetics that may have implications for the drug's efficacy and safety make a meaningful impact .
-
[Nature Sub-issue] Can you lose weight while lying down
Time of Update: 2022-01-24
The research team found that deleting specific genes in male mice reduced fat and increased muscle mass, equivalent to exercising 1 hour a day, 5 days a week for 6 weeks .
-
Zhejiang Province must inspect and classify every car to ensure the safety of cold chain food
Time of Update: 2022-01-09
According to the requirements of the “Zhejiang Province Strengthening the Management of Cold-chain Transport Vehicles to Ensure Imported Cold-chain Foods Should Be Included in the Centralized Supervi
-
my country's multiple anti-coronavirus drugs enter clinical trials
Time of Update: 2021-12-06
Li Jia, director of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences: Both new drugs have completed preclinical studies and entered clinical trials.
Li Jia, director of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences: Both new drugs have completed preclinical studies and entered clinical trials.
-
The development prospects of the biopharmaceutical market are promising, and a large number of pharmaceutical companies are spending huge sums of money to deploy
Time of Update: 2021-12-05
However, in recent years, with the expiration of patents for some original research drugs and the continuous expansion of the biopharmaceutical market, many pharmaceutical companies in China have accelerated their deployment in the biopharmaceutical field .
